 Telegraph.co.uk | Everolimus for Advanced Breast Cancer: An Update From the BOLERO-2 Trial Cancer Network At the American Society of Clinical Oncology (ASCO) Breast Cancer Symposium last week, Hope Rugo, MD, director of breast oncology and clinical trials education and professor of medicine at the UCSF Helen Diller Family Comprehensive Cancer Center in ... Wonder drug can halt breast cancer Breast cancer drug 'offers precious extra months of life' by slowing rate of ... |
